Table 2 Frequencies of mutations across the complete genome of OHBV/D as compared to HBV/D from HBsAg-positive carriers.

From: Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers

Site in HBV Amino Acid/Nucleotide Substitution

OHBV/D sequences determined in this study (n = 17)(%)

HBV/D sequences from HBsAg-Positive carriers of Eastern India (EI) (n = 62)(%)

HBV/D sequences from HBsAg-Positive carriers of other geographical regions (WRLD) (n = 105)(%)

p2 (OHBV vs HBV/D_EI)a

p1 (OHBV vs HBV/D_WRLD)a

PreS1/PreS2/S-ORF

PreS2-P36L

11(64.9)

10(16)

1(0.9)

1.97E-04

1.01E-10

PreS2-I42L

14(82.6)

16(25.6)

27(25.6)

3.59E-05

1.25E-05

P36L+I42L

11(64.9)

9(14.4)

1(0.9)

1.03E-04

1.01E-10

sT125M

16(94.4)

22(35.2)

20(19)

1.37E-05

2.48E-09

sP127T

17(100)

43(68.8)

39(37)

8.29E-03

3.82E-07

sT125M+sP127T

16(94.4)

21(33.6)

20(19)

1.02E-05

2.48E-09

X-ORF

R26C

11(64.9)

11(17.6)

19(18)

3.57E-04

1.70E-04

P33S

11(64.9)

19(30.4)

34(32.3)

2.19E-02

1.46E-02

R26C+P33S

11(64.9)

11(17.6)

10(9.5)

3.57E-04

1.84E-06

ORF-P

spE1D

12(70.8)

10(16.1)

13(12.4)

3.65E-05

1.38E-06

spI59F

10(59)

13(20.9)

22(20.9)

5.17E-03

2.23E-03

spL80F

11(64.9)

14(22.5)

35(33.3)

2.26E-03

1.68E-02

spL116F

10(59)

10(16.1)

13(12.3)

8.92E-04

7.26E-05

rtA21S

11(64.9)

15(24.2)

26(24.7)

3.01E-03

2.97E-03

rtF122L

10(59)

14(22.5)

24(22.8)

6.87E-03

6.33E-03

rtH124N

13(76.7)

9(14.5)

5(4.7)

2.58E-06

1.56E-10

rtQ130P

10(59)

17(27.4)

22(20.9)

2.19E-02

2.23E-03

rtN131D

10(59)

9(14.5)

4(3.8)

4.97E-04

1.11E-07

rtD263E

14(82.6)

28(45.1)

40(38)

1.20E-02

1.04E-03

rtV278I

11(64.9)

8(12.9)

14(13.3)

5.10E-05

4.57E-05

rhL30S

11(64.9)

7(11.3)

10(9.5)

2.35E-05

1.84E-06

rhL55I

14(82.6)

27(43.5)

38(36.1)

5.79E-03

4.53E-04

X-Promoter

T1050G

12(70.6)

12(19.4)

12(11.4)

1.29E-04

7.52E-07

A1053G

11(64.7)

11(17.7)

10(9.5)

3.57E-04

1.84E-06

C1059T

11(64.7)

13(21)

14(13.3)

1.89E-03

1.85E-05

C1350A

11(64.7)

8(12.9)

2(1.9)

5.10E-05

6.21E-10

Enh-II

C1637A

11(64.7)

9(14.5)

9(8.6)

1.03E-04

9.23E-07

T1676A

12(70.6)

13(21)

7(6.7)

2.28E-04

1.77E-08

  1. aFisher’s exact test, p value; ORF, open reading frame; sp, spacer; rt, reverse transcriptase; rh, RNaseH.